NDAORALTABLET
Approved
Jul 1944
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 28m ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Dicumarol is an oral anticoagulant tablet approved in 1944, representing one of the earliest synthetic coumarins used to prevent blood clots. It works by inhibiting vitamin K-dependent clotting factors, reducing thrombus formation in patients at risk for thromboembolism. This legacy drug has largely been superseded by warfarin and newer anticoagulants but remains available for specific patient populations.
LOE Approaching
This legacy asset faces imminent loss of exclusivity with minimal commercial infrastructure, indicating small brand team and focus on managed decline rather than growth.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on dicumarol offers limited career growth within AbbVie, as the product is in decline with zero linked job opportunities and no active development pipeline. Roles available are primarily sustaining and administrative, focused on maintaining compliance and managing lifecycle rundown rather than innovation or market expansion.
Regulatory Affairs SpecialistCompliance Manager
Worked on DICUMAROL at AbbVie? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.